glp-1 (7-36) amide
Peptideexperimental
Clinical trial activity
6 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2011 (NCT01333163)
Timeline
No events for the selected filters.
Mechanism of action
GIPR agonist
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- glp-1 (7-36) amide
- glp-1 (7-36) amide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04186026 | N/A | Oct 1, 2019 | University of Copenhagen |
| NCT03950245 | N/A | May 31, 2019 | University of Copenhagen |
| NCT03835013 | N/A | Feb 11, 2019 | University of Cambridge |
| NCT03502083 | N/A | Dec 1, 2015 | Papworth Hospital NHS Foundation Trust |
| NCT02598791 | N/A | Oct 1, 2015 | University of Copenhagen |
| NCT01333163 | N/A | May 1, 2011 | Aarhus University, Novo Nordisk |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Copenhagen | Academic/Hospital | 3 | 3 | 1 | 2015 |
| Aarhus University | Academic/Hospital | 1 | 1 | 1 | 2011 |
| Novo Nordisk | For profit | 1 | 0 | 1 | 2011 |
| Papworth Hospital NHS Foundation Trust | Academic/Hospital | 1 | 1 | 1 | 2015 |
| University of Cambridge | Academic/Hospital | 1 | 1 | 1 | 2019 |
5 organizations
Page 1 / 1